Esperion to Report First Quarter 2026 Financial Results on May 7

Esperion (NASDAQ: ESPR) will report first quarter 2026 financial results before the market opens on May 7, 2026.

Rhea-AI Summary

Esperion (NASDAQ: ESPR) will report first quarter 2026 financial results before the market opens on May 7, 2026.

Management will host a live webcast at 8:00 a.m. ET the same day to discuss results and business updates; a replay will be available about two hours after the call and archived for ~90 days.

Argus Apr 23 session

-3.05% close to close Open Argus

Details

News Market Reaction – ESPR

On Apr 23, the day this news came out, ESPR closed 3.05% below the previous close.

Data tracked by StockTitan Argus for the Apr 23 session.

Market Context

This announcement sets expectations for ESPR’s Q1 2026 update, specifying a May 7, 2026 release and ...

Analysis

This announcement sets expectations for ESPR’s Q1 2026 update, specifying a May 7, 2026 release and an 8:00 a.m. ET webcast with a replay archived for about 90 days. Historically, similar earnings-date notices have prompted only modest share moves, suggesting investors treat them as routine information. Given recent clinical, guideline, and acquisition news, the actual financial details and forward commentary at the Q1 call remain the key catalysts to monitor.

Key Figures

Earnings release date: May 7, 2026 Webcast time: 8:00 a.m. ET Replay duration: approximately 90 days

Earnings release date

May 7, 2026

Q1 2026 financial results release before market open

Webcast time

8:00 a.m. ET

Management webcast to discuss Q1 2026 results

Replay duration

approximately 90 days

Webcast replay archived on company website

Previous Earnings date Reports

1 past event · Latest: Feb 24

Same Type 1 event

1. Feb 24

   Earnings date notice

   24h Move

   -1.2%

   Scheduled Q4 and full-year 2025 results with webcast details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2026 financial results before the market opens on Thursday, May 7, 2026.

Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates.

A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

About Esperion Therapeutics 
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies. The Company leverages deep domain expertise in ACLY biology to develop and commercialize transformative medicines for patients worldwide. Esperion currently markets two oral, once-daily, non-statin therapies for patients struggling to maintain their low-density lipoprotein cholesterol (LDL-C) levels and are at risk of cardiovascular disease.  

With a broad U.S. commercial infrastructure and global approvals across more than 40 countries, Esperion is well positioned to serve as a partner-of-choice for global innovators seeking U.S. market access through acquisition, in-license, co-promotion and revenue share opportunities. In tandem, the Company is advancing its leadership in ACLY biology to build a diversified pipeline of novel product candidates, including treatments for Primary Sclerosing Cholangitis and renal diseases. For more information, visit esperion.com and follow Esperion on LinkedIn and X. 

Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903

Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Esperion (ESPR) report Q1 2026 results and what is the schedule?

Esperion will report Q1 2026 results before market open on May 7, 2026. According to the company, management will host a live webcast at 8:00 a.m. ET to discuss the results and provide business updates, with a replay available later.

How can investors access the Esperion (ESPR) Q1 2026 earnings webcast on May 7?

Investors can access the live audio webcast via Esperion's investor and media website. According to the company, the live stream will be available at 8:00 a.m. ET and a replay will be archived on the website for about 90 days.

Will the Esperion (ESPR) Q1 2026 webcast have a replay and how long will it be available?

Yes, a replay will be posted approximately two hours after the call and archived for about 90 days. According to the company, the replay will be accessible from the investor section of Esperion's website for that period.

What topics will Esperion (ESPR) management cover during the May 7, 2026 webcast?

Management will discuss first quarter 2026 financial results and provide business updates during the webcast. According to the company, the session is intended to review results and offer commentary on near-term business developments.

What time should shareholders tune in for Esperion's (ESPR) May 7, 2026 webcast?

Shareholders should tune in at 8:00 a.m. ET on May 7, 2026 for the live webcast. According to the company, the webcast follows the pre-market release of first quarter 2026 financial results and includes a management discussion.